All Work

Jon C. Ogg

Triple Leverage ETFs Launched in Biotech

For active traders and investors looking for juiced up returns in the hot biotech sector, ProShares has launched two triple leverage exchange traded funds in biotech.

Jon C. Ogg · 11 years ago

Is Energy XXI Worth Over 50% More?

Energy XXI could have a solid bounce heading its way if Canaccord Genuity is correct in its latest research report.

Jon C. Ogg · 11 years ago

3 Key Stock Buybacks From Monday

Investors love stock buyback plans. Still, not all share repurchases are created equal. 24/7 Wall St. tracked three standout buyback announcements from Monday.

Jon C. Ogg · 11 years ago

Is Calpine Really Worth 50% More?

Independent research firm Argus has a report out that may indicate that Calpine could be worth literally 50% more than its current price.

Jon C. Ogg · 11 years ago

Chicago Fed Shows Cooling National Economy in May

ThinkstockMonthly data released from the Federal Reserve Bank of Chicago showed that economic growth was slightly below average in May. The Chicago Fed National Activity Index, an index that is a weighted average of…

Jon C. Ogg · 11 years ago

5 Analyst Stocks With 50% to 100% Upside Potential

ThinkstockThis past week was exciting, with the Nasdaq finally surpassing its old high from March of 2000 and with the markets trying to price in the impact of a likely Greek exit from the…

Jon C. Ogg · 11 years ago